... Salva M, Anton F, Miralpeix M, Beleta J,Gavalda A: Aclidinium bromide, a new, long-acting, inhaled muscarinicantagonist: In vitro plasma inactivation and pharmacological activity of its main ... number of pharmaceutical companies,including Almirall, for speaking at meetings and for consulting and participating in advisory board meetings, and has also received support forresearch from ... the acceptability and repeatability of the dataaccording to A TS/ERS acceptability criteria.Health status and dyspnoea were evaluated pre-dose onDay 1 (baseline) and at Weeks 12, 28, 44 and...